BTREX PLUS, Dietary Supplement 2 Caplets, UPC 05380930802 (Physician Samples)
Reported: May 26, 2021 Initiated: July 13, 2020 #F-0540-2021
Product Description
BTREX PLUS, Dietary Supplement 2 Caplets, UPC 05380930802 (Physician Samples)
Reason for Recall
CGMP Deviations: Presence of damaged tablets
Details
- Recalling Firm
- Lopez Gonzalez Santana Corporation
- Units Affected
- lots #32179 1405 and Lot #33278 - 0.
- Distribution
- Domestic distribution only-PR
- Location
- Rio Piedras, PR
Frequently Asked Questions
What product was recalled? ▼
BTREX PLUS, Dietary Supplement 2 Caplets, UPC 05380930802 (Physician Samples). Recalled by Lopez Gonzalez Santana Corporation. Units affected: lots #32179 1405 and Lot #33278 - 0..
Why was this product recalled? ▼
CGMP Deviations: Presence of damaged tablets
Which agency issued this recall? ▼
This recall was issued by the FDA Food on May 26, 2021. Severity: Low. Recall number: F-0540-2021.
Related Recalls
FDA Drug Moderate
Bisoprolol Fumarate and Hydrochlorothiazide tablets, USP, 2.5 mg/6.25 mg, 100-count bottle, Rx Only, Manufactured by: U…
Unichem Pharmaceuticals USA Inc. · 2026-02-11
FDA Drug Critical
Green Lumber Natural Fuel For Men capsule, packaged in 2, 4, 10, and 30-count blister packs. GreenLumber.com, 2618 San…
Green Lumber Holdings, LLC · 2026-02-11
FDA Drug Moderate
Trazodone Hydrochloride, USP, 50 mg, 100-Count Bottle, Rx only, Manufactured by: Granules India Limited, Hyderabad, 500…
Granules Pharmaceuticals Inc. · 2026-02-11
FDA Drug Critical
Diclofenac Sodium, Topical Gel, 3%, 100 g, Rx only, Mfd. by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada L6T 1…
SUN PHARMACEUTICAL INDUSTRIES INC · 2026-02-11
FDA Drug Critical
Rheumacare capsules, 30 count bottle, Mfg in India by: Virgo UAP Pharma Pvt. Ltd., Ahmedabad, India UPC 8 904218 700313
HANDELNINE GLOBAL LLC · 2026-02-11